Search Results - "Vasilopoulou, Foteini"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I2-Imidazoline Receptor Ligand MCR5 by Vasilopoulou, Foteini, Bagan, Andrea, Rodriguez-Arevalo, Sergio, Escolano, Carmen, Griñán-Ferré, Christian, Pallàs, Mercè

    Published in Pharmaceutics (23-05-2020)
    “…Behavioural and psychological symptoms of dementia (BPSD), including fear-anxiety- and depressive-like behaviour, are present in Alzheimer’s disease (AD),…”
    Get full text
    Journal Article
  2. 2

    I2 imidazoline receptor modulation protects aged SAMP8 mice against cognitive decline by suppressing the calcineurin pathway by Vasilopoulou, Foteini, Griñán-Ferré, Christian, Rodríguez-Arévalo, Sergio, Bagán, Andrea, Abás, Sònia, Escolano, Carmen, Pallàs, Mercè

    Published in GeroScience (01-04-2021)
    “…Brain aging and dementia are current problems that must be solved. The levels of imidazoline 2 receptors (I 2 -IRs) are increased in the brain in Alzheimer’s…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Microglia and TREM2 by Pocock, Jennifer, Vasilopoulou, Foteini, Svensson, Elina, Cosker, Katharina

    Published in Neuropharmacology (01-10-2024)
    “…TREM2 is a membrane receptor solely expressed on microglia in normal brain. In this review we outline recent advances in TREM2 biology and its implications for…”
    Get full text
    Journal Article
  5. 5

    Disease‐modifying treatment with I2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil by Vasilopoulou, Foteini, Rodríguez‐Arévalo, Sergio, Bagán, Andrea, Escolano, Carmen, Griñán‐Ferré, Christian, Pallàs, Mercè

    Published in British journal of pharmacology (01-08-2021)
    “…Background and Purpose The development of effective therapeutic strategies against Alzheimer's disease (AD) remains a challenge. I2 imidazoline receptor…”
    Get full text
    Journal Article
  6. 6

    Disease-modifying treatment with I 2 imidazoline receptor ligand LSL60101 in an Alzheimer's disease mouse model: a comparative study with donepezil by Vasilopoulou, Foteini, Rodríguez-Arévalo, Sergio, Bagán, Andrea, Escolano, Carmen, Griñán-Ferré, Christian, Pallàs, Mercè

    Published in British journal of pharmacology (01-08-2021)
    “…The development of effective therapeutic strategies against Alzheimer's disease (AD) remains a challenge. I imidazoline receptor ligands have a neuroprotective…”
    Get full text
    Journal Article
  7. 7

    11β-HSD1 Inhibition by RL-118 Promotes Autophagy and Correlates with Reduced Oxidative Stress and Inflammation, Enhancing Cognitive Performance in SAMP8 Mouse Model by Puigoriol-Illamola, Dolors, Griñán-Ferré, Christian, Vasilopoulou, Foteini, Leiva, Rosana, Vázquez, Santiago, Pallàs, Mercè

    Published in Molecular neurobiology (01-12-2018)
    “…Elevated glucocorticoid (GC) exposure is widely accepted as a key factor in the age-related cognitive decline in rodents and humans. 11β-HSD1 is a key enzyme…”
    Get full text
    Journal Article
  8. 8

    Microarray Analysis Revealed Inflammatory Transcriptomic Changes after LSL60101 Treatment in 5XFAD Mice Model by Vasilopoulou, Foteini, Escolano, Carmen, Pallàs, Mercè, Griñán-Ferré, Christian

    Published in Genes (26-08-2021)
    “…I2-IR have been found dysregulated in patients with neurodegenerative diseases, such as Alzheimer's disease (AD), in which the importance of neuroinflammation…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Amelioration of BPSD-Like Phenotype and Cognitive Decline in SAMP8 Mice Model Accompanied by Molecular Changes after Treatment with I 2 -Imidazoline Receptor Ligand MCR5 by Vasilopoulou, Foteini, Bagan, Andrea, Rodriguez-Arevalo, Sergio, Escolano, Carmen, Griñán-Ferré, Christian, Pallàs, Mercè

    Published in Pharmaceutics (23-05-2020)
    “…Behavioural and psychological symptoms of dementia (BPSD), including fear-anxiety- and depressive-like behaviour, are present in Alzheimer's disease (AD),…”
    Get full text
    Journal Article
  15. 15

    I 2 imidazoline receptor modulation protects aged SAMP8 mice against cognitive decline by suppressing the calcineurin pathway by Vasilopoulou, Foteini, Griñán-Ferré, Christian, Rodríguez-Arévalo, Sergio, Bagán, Andrea, Abás, Sònia, Escolano, Carmen, Pallàs, Mercè

    Published in GeroScience (01-04-2021)
    “…Brain aging and dementia are current problems that must be solved. The levels of imidazoline 2 receptors (I -IRs) are increased in the brain in Alzheimer's…”
    Get full text
    Journal Article
  16. 16
  17. 17